ARTICLE | Clinical News
Revolade eltrombopag regulatory update
February 16, 2015 8:00 AM UTC
Ligand said GlaxoSmithKline submitted a regulatory application to EMA to expand the label of Revolade eltrombopag to include the treatment of chronic idiopathic thrombocytopenic purpura (ITP) in pedia...